Skip to Main Content

Wei Shen Tan, MD, PhD

Assistant Professor
DownloadHi-Res Photo

Training

Fellow, Urologic Oncology
University of Texas MD Anderson Cancer Center


Fellow, Robotic Urology
University College London Hospitals


About

Titles

Assistant Professor

Biography

Wei Shen Tan, MD, PhD, FRCS is a urologic oncologist with expertise in the treatment of bladder, prostate and kidney cancers. He completed his Society of Urologic Oncology (SUO)-accredited fellowship at the prestigious University of Texas MD Anderson Cancer Center, Houston, TX and a robotic urology fellowship at University College London Hospital, London, UK. Dr. Tan completed his urology residency through the London School of Surgery and is a Fellow of the Royal College of Surgeons of England.

Dr. Tan holds a PhD in Uro-oncology, with his research focusing on genitourinary cancers. His key interests include: 1) Cancer diagnostics, 2) Novel treatments for bladder cancer, 3) Biomarker development for bladder cancer, 4) Characterization of non-muscle-invasive bladder cancer and 5) Optimizing perioperative outcomes following radical cystectomy through enhanced recovery protocols and robotic surgery.

He is a co-investigator in several major clinical trials, including DETECT I & II, HYMN, BOXIT, and HIVEC-II. His work has resulted in over 100 peer-reviewed publications. Dr. Tan also serves on the editorial boards of the British Journal of Urology International and the Journal of Men’s Health.

Appointments

  • Urology

    Assistant Professor
    Primary

Other Departments & Organizations

Education & Training

Fellow, Urologic Oncology
University of Texas MD Anderson Cancer Center
Fellow, Robotic Urology
University College London Hospitals
Resident, Urology
London School of Surgery
Non Degree Program
Royal College of Surgeons of England
PhD
University College London
MD
Cardiff University
BSc
University College London

Research

Overview

Medical Subject Headings (MeSH)

Non-Muscle Invasive Bladder Neoplasms; Transurethral Resection of Bladder; Urinary Bladder Neoplasms

Research at a Glance

Publications Timeline

A big-picture view of Wei Shen Tan's research output by year.
181Publications
2,479Citations

Publications

2024

Clinical Care

Overview

Wei Shen Tan, MD, PhD, is a urologic oncologist who treats bladder, prostate, and kidney cancer.

Dr. Tan says he was drawn to his specialty because of the variety of conditions and treatments it offers. “We treat patients with surgery but also with medications and other treatments,” he says. “Surgery is one of the treatment options available, particularly with urologic cancers.”

When working with patients, Dr. Tan says he customizes care to their needs. “My task is to guide patients from cancer diagnosis to giving them the information they need so that we can make a joint decision in how to approach their care and move forward,” he says. “My preferred approach if we are going with surgical treatment, is minimally invasive robotic surgery, where possible. This allows the patient to recover much quicker and get on with their lives.”

Recognizing that cancer is a difficult diagnosis for patients to accept, Dr. Tan says he makes it a priority to be frank with them and offer realistic expectations. “I make sure I fully explain their treatment options and customize the information for them,” he says.

Dr. Tan’s research focuses on bladder cancer, including optimizing ways to investigate patients for cancer, characterization of cancer to allow a personalized approach and well as novel therapies. “I’m interested in tailoring treatments appropriately to minimize overtreatment and provide the best care for them,” he says.

Clinical Specialties

Urology

Fact Sheets

Board Certifications

  • Urology

    Certification Organization
    Royal College of Surgeons of England
    Original Certification Date
    2022

Yale Medicine News

Get In Touch

Contacts

Appointment Number
Mailing Address

Yale Medicine

789 Howard St, FMP 315

New Haven, CT 06519

United States